GGrantIndex
Sort

40,608 grants matching prostate cancer

Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer

$817,180
Hui Zhang · Johns Hopkins University · U01 · FY2020 · CA

Uses of GEM models for Translational Cancer Research

$817,169
Lynda Chin · Dana-Farber Cancer Inst · U01 · FY2011 · CA

Strategies for Therapeutic Cancer Vaccine Clinical Trials

$816,925
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

CANCER AWARENESS NETWORK FOR IMMIGRANT MINORITY POPULATI

$816,913
New York University School Of Medicine · U01 · FY2004 · CA

Cancer Risk in Human Populations

$816,676
Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

Nutrition, Metabolism, and Cancer

$816,583
Regina G Ziegler · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

TARGET HSD3B1- ASSOCIATED EXTRAGONADAL ANDROGEN BIOSYNTHESIS TO SENSITIZE LETHAL PROSTATE CANCER

$816,400
The Cleveland Clinic Foundation · · FY2018 · Department of the Army

Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3

$816,289
Elio Riboli · Imperial College Of Science, Technology And Medicine · U01 · FY2010 · CA

Mouse Models of Prostate Cancer

$816,228
Fred Hutchinson Cancer Research Center · U01 · FY2005 · CA

ATECAR: Asian Training, Education on Cancer & Research

$816,182
Grace X Ma · Temple Univ Of The Commonwealth · U01 · FY2009 · CA

Prostate Cancer in a Black Population

$816,172
Barbara Nemesure · State University New York Stony Brook · R01 · FY2010 · CA

High Energy and Spatial Resolution Multi-Isotope SPECT Imaging of Targeted Alpha-Emitters and their Daughters

$816,098
Yong Du · Johns Hopkins University · U01 · FY2025 · EB

Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States

$815,131
Xuehong Zhang · Brigham And Women'S Hospital · U01 · FY2022 · CA

Germline modifiers of tumor progression and metastasis in prostate cancer

$814,460
Nigel Crawford · National Human Genome Research Institute · ZIA · FY2015 · HG

Center for Allaying Health Disparities Through Research and Education (CADRE)

$814,386
John W Garland · Central State Univ (Wilberforce, Oh) · P20 · FY2008 · MD

A Randomized Hybrid Type I effectiveness-implementation study of an Ehealth delivery Alternative for Cancer genetic testing for Hereditary cancer predisposition (eREACH)

$814,286
Angela R. Bradbury · University Of Pennsylvania · U01 · FY2020 · CA

A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins

$814,258
Nimmi Ramanujam · Duke University · R01 · FY2015 · EB

IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells

$814,121
Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2021 · CA

Mechanisms of resistance to treatment in aggressive prostate cancers

$813,992
Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Molecular alterations driving the development of primary prostate cancers

$813,992
Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Novel Targets for Vaccine Therapy

$813,239
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

$813,237
Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2023 · CA

DIETARY AND BIOCHEMICAL MARKERS OF PROSTATE CANCER RISK

$812,950
Brigham And Women'S Hospital · R01 · FY2001 · CA

SWOG Biospecimen Bank

$812,707
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA

Complementary Adenoviral Vectors for Treatment of Cancer

$812,500
Magnum Therapeutics · R44 · FY2003 · CA